These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2343674)
1. [Different types of blood lipoproteins in psoriasis patients. 1. The relationship of dyslipoproteinemias due to disordered cholesterol transport and the course of psoriasis]. Keshileva ZB; Kosukhin AB; Polevaia LG; Nusupova ZhA Vestn Dermatol Venerol; 1990; (2):7-11. PubMed ID: 2343674 [TBL] [Abstract][Full Text] [Related]
2. [The combination of psoriasis with different types of lipoproteinemias. 2. The characteristics of the dyslipoproteinemias caused by disorders in triacylglyceride transport in psoriasis]. Keshileva ZB; Kosukhin AB; Polevaia LG Vestn Dermatol Venerol; 1990; (5):7-11. PubMed ID: 2402946 [TBL] [Abstract][Full Text] [Related]
3. [Characteristics of cholesterol transport by various classes of lipoproteins and their apolipoproteins in hypo- and hyperalphalipoproteinemia]. Perova NV; Chernysheva NP; Shcherbakova IA; Polesskiĭ VA Kardiologiia; 1979 Dec; 19(12):66-71. PubMed ID: 229299 [TBL] [Abstract][Full Text] [Related]
4. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study. Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681 [TBL] [Abstract][Full Text] [Related]
5. [Characteristics of the lipid transport system in psoriasis]. Torkhovskaia TI; Fortinskaia ES; Ivanova LI; Nikitina NA; Zakharova TS; Kochetova MM; Kliuchnikova ZhI; Sharapova GIa; Khalilov EM Vopr Med Khim; 2002; 48(3):297-303. PubMed ID: 12243089 [TBL] [Abstract][Full Text] [Related]
6. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
7. [Preparative subfractionation of high-density lipoproteins in dysalphalipoproteinemias]. Perova NV; Shcherbakova IA; Nikitina NA; Nikols AV; Blansh PD Vopr Med Khim; 1985; 31(6):118-23. PubMed ID: 4090377 [TBL] [Abstract][Full Text] [Related]
8. Dyslipoproteinemias after heart and heart-lung transplantation: potential relation to accelerated graft arteriosclerosis. Bilodeau M; Fitchett DH; Guerraty A; Sniderman AD J Heart Transplant; 1989; 8(6):454-9. PubMed ID: 2614546 [TBL] [Abstract][Full Text] [Related]
9. [High density lipoproteins of the blood plasma and dysalphalipoproteinemia (a review)]. Polikarpova LI Vopr Med Khim; 1981; 27(5):579-90. PubMed ID: 7032061 [No Abstract] [Full Text] [Related]
10. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [TBL] [Abstract][Full Text] [Related]
11. [Self-regulation of the functional state of high density lipoproteins and its disorders in hypoalphacholesterolemia (review]. Gerasimova EN; Perova NV Vopr Med Khim; 1985; 31(1):32-40. PubMed ID: 3885566 [TBL] [Abstract][Full Text] [Related]
12. Unsaturated fatty acids incorporated in HDL in hypo- and hyperalphalipoproteinemia--relation to the HDL-cholesterol level. Vecera R; Chmela Z; Hrebícek J; Skottová N Acta Univ Palacki Olomuc Fac Med; 1994; 137():35-8. PubMed ID: 7778503 [TBL] [Abstract][Full Text] [Related]
13. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias]. Apostolov I; Naumova R; Balabanski L; Goranov I Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586 [TBL] [Abstract][Full Text] [Related]
14. [Apoproteins C and E from very low and high density lipoproteins in men with dysalphalipoproteinemia]. Shcherbakova IA; Gerasimova EN; Perova NV; Chernyshova NP Vopr Med Khim; 1982; 28(3):117-23. PubMed ID: 7101813 [TBL] [Abstract][Full Text] [Related]
15. [Age-related characteristics of the normal blood content of lipids and lipoproteins and in arterial hypertension]. Tokar AV; Chaialo PP; Rudaia ES; Shevchenko VA Vutr Boles; 1983; 22(5):71-6. PubMed ID: 6673337 [TBL] [Abstract][Full Text] [Related]
16. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498 [TBL] [Abstract][Full Text] [Related]
17. [High density lipoprotein cholesterol in secondary hyperlipoproteinemias]. Titov VN; Tvorogova MG; Kantardzhian IG; Alamdarova IA; Negovskaia AV Lab Delo; 1983; (12):11-7. PubMed ID: 6201650 [TBL] [Abstract][Full Text] [Related]
18. Activity of serum lipase [EC 3.1.1.3] and the diversity of serum lipid profile in psoriasis. Pietrzak A; Lecewicz-Toruń B Med Sci Monit; 2002 Jan; 8(1):CR9-CR13. PubMed ID: 11782673 [TBL] [Abstract][Full Text] [Related]
19. Serum lipoproteins in middle-aged men with psoriasis. Vahlquist C; Michaëlsson G; Vessby B Acta Derm Venereol; 1987; 67(1):12-5. PubMed ID: 2436408 [TBL] [Abstract][Full Text] [Related]
20. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]